Target intelligence / Profile preview

Phosphatidylinositol-glycan biosynthesis class X protein (PIGX)

Target
PIGX
Molecular classification
Enzyme (regulatory subunit of glycosyltransferase complex), Other (stabilizer of mannosyltransferase complex)
01

Overview

Phosphatidylinositol-glycan biosynthesis class X protein (PIGX) is a stabilizing subunit essential for the GPI alpha-1,4-mannosyltransferase I enzyme complex, which is responsible for transferring the first mannose in the glycosylphosphatidylinositol (GPI) anchor biosynthetic pathway within the endoplasmic reticulum. PIGX itself ensures stability and enzymatic function of PIGM, the main catalytic subunit, and is required for proper cell surface expression of GPI-anchored proteins, which have roles in signal transduction, immune response, cell adhesion, and enzymatic functions. PIGX is upregulated in some cancers such as breast cancer, contributing to cell proliferation through negative regulation of tumor suppressor genes EHD2 and ZIC1. While there are currently no drugs known to directly target PIGX, its critical function makes it a potential future target for anticancer agents, though broad inhibition is likely to cause significant toxicity due to disruption of multiple essential cell-surface proteins.

Other names
GPI alpha-1,4-mannosyltransferase I, stabilizing subunitPIG-XFLJ20522phosphatidylinositol-glycan biosynthesis class X proteinGPI-mannosyltransferase subunit
02

Biological functions

Glycosylphosphatidylinositol anchor biosynthesisRegulation of GPI-anchored protein expressionCell surface protein anchoringRegulation of cell proliferation (via suppression of EHD2 and ZIC1)
03

Disease associations

Cancer (particularly breast cancer, where it is upregulated and promotes cell proliferation)GPI-deficiency syndromes (loss or mutation disrupts GPI-anchored protein presentation)
04

Safety considerations

Potential toxicity from interfering with GPI-anchor biosynthesis, which could affect >150 cell surface proteins essential for key biological functionsRisk of broad side effects due to fundamental role in cell-surface protein presentation

Beyond the preview

Go deeper on Phosphatidylinositol-glycan biosynthesis class X protein (PIGX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol-glycan biosynthesis class X protein (PIGX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call